NBC News: New Alzheimer's drug comes with steep price tag

UC expert says doctors, patients will have to consider financial burden when making decision

Leqembi, a newly approved drug for use in people with mild cognitive impairment or early Alzheimer's disease, comes with a price of $26,500 a year.

Experts say the high price, along with Medicare only covering the drug for patients enrolled in a clinical trial, will mean only a limited number of patients will be able to get the drug when it becomes available.

The University of Cincinnati's Alberto Espay, MD, professor of neurology in the UC College of Medicine, director and endowed chair of the James J. and Joan A. Gardner Family Center for Parkinson’s Disease and Movement Disorders at the UC Gardner Neuroscience Institute and a UC Health physician, told NBC News the price of the drug is "very unfortunate."

Espay said doctors will need to include the financial burden as a possible risk of the drug when discussing its potential benefits of modestly slowing the disease. He is a proponent of an alternative theory that it is the loss of the normal amyloid protein, rather than the build-up of the abnormal amyloid plaques, that leads to degeneration.

Previously, Espay noted the benefits of Leqembi may stem from the fact that it increases levels of the normal protein in the brain in addition to its primary aim of removing plaques.

Read the NBC News article on the price of Leqembi.

Read the NBC News article featuring Espay about unanswered questions about Leqembi.

Espay also discussed Leqembi and the state of Alzheimer's research on WVXU's Cincinnati Edition. Listen to the Cincinnati Edition segment.

Read more about Espay's research and alternative Alzheimer's hypothesis.

Featured photo at top courtesy of Unsplash.

Related Stories

9858 Results
4

Camp aims to empower children, teens who stutter

July 17, 2024

A one-week, evidence-based program for children and teens who stutter at the University of Cincinnati will teach kids to communicate effectively, advocate for themselves and develop confidence about their communication abilities. Camp Dream. Speak. Live., which is coming to Cincinnati for the first time July 22-26, began in 2014 at the University of Texas at Austin. The Arthur M. Blank Center for Stuttering Education and Research at UT expects to serve more than 2,000 children at camps across the United States, Africa, Asia and Europe this year.

5

UC Blue Ash takes next step in major renovation project

July 17, 2024

Muntz Hall, the flagship building on the University of Cincinnati Blue Ash College campus, is in the next phase of a major renovation project that will dramatically transform the main entrance, enhance access to student support services and add new spaces for students to study or meet between classes.

8

U.S. stroke survival is improving, but race still plays role

July 16, 2024

U.S. News & World Report, HealthDay and Real Health covered new research from the University of Cincinnati that found overall rates of long-term survival following stroke are improving, but Black individuals experience worse long-term outcomes compared to white individuals.

9

Collaborative pianist and vocal coach Kirill Kuzmin joins CCM’s faculty

July 16, 2024

UC College-Conservatory of Music Interim Dean Jonathan Kregor has announced the addition of Kirill Kuzmin to the college’s faculty of distinguished performing and media arts experts, researchers and educators. A Grammy-nominated collaborative pianist and vocal coach, Kuzmin begins his new role as Associate Professor of Opera/Vocal Coaching on Aug. 15, 2024.